The information below identifies new/reinstated & terminated labelers. This page will be updated as new information is available so please check back often.
For definitions of optional and mandatory effective dates, please see the Medicaid National Drug Rebate Agreement (NDRA). Additionally, the Drug Manufacturer Contact Information contains Optional Effective Date, Termination Date (if applicable), and Legal, Invoice and Technical Contact information for each drug company participating in the MDRP.
New/Reinstated Labelers
| Labeler Code | Labeler Name | Optional Effective Date (for State Coverage) | Mandatory Effective Date (for State Coverage) |
|---|---|---|---|
| 73063 | AMYLYX PHARMACEUTICALS | 11/22/2022 | 04/01/2023 |
| 81288 | EMC PHARMA, LLC | 11/16/2022 | 04/01/2023 |
| 76961 | SPECTRUM PHARMACEUTICALS, INC. | 11/09/2022 | 04/01/2023 |
| 82429 | GABAR HEALTH SCIENCE | 10/26/2022 | 01/01/2023 |
| 81968 | AXSOME THERAPEUTICS, INC. | 10/20/2022 | 01/01/2023 |
| 73077 | FENNEC PHARMACEUTICALS, INC. | 10/19/2022 | 01/01/2023 |
| 65086 | SANTEN, INC. | 10/07/2022 | 01/01/2023 |
| 69681 | VERU INC. | 09/28/2022 | 01/01/2023 |
| 82249 | CIVICASCRIPT, LLC | 09/26/2022 | 01/01/2023 |
| 81665 | OMNIVIUM PHARMACEUTICAL | 09/20/2022 | 01/01/2023 |
| 81298 | LONG GROVE PHARMACEUTICALS, LLC | 09/12/2022 | 01/01/2023 |
| 81140 | PROTEGA PHARMACEUTICALS LLC | 09/07/2022 | 01/01/2023 |
| 80735 | CIPLA THERAPEUTICS INC. | 09/02/2022 | 01/01/2023 |
| 81583 | MARINUS PHARMACEUTICALS INC. | 08/25/2022 | 01/01/2023 |
| 73683 | NOBELPHARMA AMERICA, LLC | 08/25/2022 | 01/01/2023 |
| 82293 | NOVUGEN PHARMA (USA) LLC | 08/19/2022 | 01/01/2023 |
| 80610 | ARCUTIS BIOTHERAPEUTICS, INC. | 08/18/2022 | 01/01/2023 |
Terminated Labelers
| Labeler Code | Labeler Name | Effective Date |
|---|---|---|
| 73320 | KARTHA PHARMACEUTICALS | 01/01/2023 |
| 69087 | CLARUS THERAPEUTICS, INC. | 01/01/2023 |
| 65293 | THE MEDICINES COMPANY | 01/01/2023 |
| 52565 | TELIGENT PHARMA, INC. | 01/01/2023 |
| 52440 | TITAN PHARMACEUTICALS, INC. | 01/01/2023 |
| 00299 | GALDERMA LABORATORIES, L.P. | 01/01/2023 |
| 00225 | B. F. ASCHER AND COMPANY, INC. | 01/01/2023 |
| 62541 | VIVUS LLC | 01/01/2023 |
| 55792 | LUKARE MEDICAL, LLC | 01/01/2023 |
For questions, please contact MDRP Operations at MDROperations@cms.hhs.gov.
Disclaimer: Please note that the information provided on this web page does not bind or obligate the Centers for Medicare and Medicaid Services (CMS). The statements included on this web page are intended to provide information on New/Reinstated & Terminated Labelers and do not in any way revise or modify the requirements set forth in Section 1927 of the Act, the national drug rebate agreement (NDRA), subsequent program releases, or regulations.
Page last updated on December 1, 2022